Global Information
회사소개 | 문의 | 비교리스트

세계의 RWE(Real World Evidence) 솔루션 시장 : 컴포넌트별(데이터 세트, 전자건강기록, 서비스), 용도별(약제 개발/승인(종양, 신경증, 면역질환), 시장 접근, 의료기기 개발), 최종사용자별 예측(-2027년)

Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027

리서치사 Meticulous Market Research Pvt. Ltd.
발행일 2020년 12월 상품코드 973572
페이지 정보 영문 194 Pages 배송안내
가격
US $ 4,175 ₩ 5,931,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄는 1회에 한해 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,875 ₩ 11,187,000 PDF (Global Site License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 RWE(Real World Evidence) 솔루션 시장 : 컴포넌트별(데이터 세트, 전자건강기록, 서비스), 용도별(약제 개발/승인(종양, 신경증, 면역질환), 시장 접근, 의료기기 개발), 최종사용자별 예측(-2027년) Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027
발행일 : 2020년 12월 페이지 정보 : 영문 194 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 RWE 솔루션 시장은 2020-2027년간 16.5%의 연평균 복합 성장률(CAGR)을 나타내고, 2027년에는 31억 3,000만 달러에 이를 것으로 예상되고 있습니다. 컴포넌트별로는 데이터 세트 분야가, 용도별로는 약제 개발/승인 분야가 최대 부문입니다. 지역별로는 북미 국가가 세계 최대 시장이며, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카가 그 뒤를 잇고 있습니다.

세계의 RWE(Real World Evidence)솔루션 시장을 분석했으며, 시장의 기본 구조, 주요 시장 성장 촉진요인 및 억제요인, 전체적인 시장 동향 전망(향후 8년간), 컴포넌트별·용도별·최종사용자별·지역별 상세 동향, 최근의 시장 경쟁 및 자본거래 동향, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 분석 방법

제3장 개요

제4장 시장 인사이트

  • 서론
  • 시장 성장 촉진요인
    • 고령자의 만성질환 부담 증대
    • 약제 개발 지연과 그에 따른 개발비 증가
    • 맞춤형 의료에 대한 주목 증대
    • Value-Based Care로의 전환
    • COVID-19의 영향 평가
    • 의료 분야용 빅데이터의 급성장
  • 시장 성장 억제요인
    • 꺼려하는 RWE 연구에 대한 의존
  • 과제
    • RWE 개발을 위한 표준 방법론 부재
  • 시장 기회
    • 신흥국가
    • End-to-End RWE 서비스에 대한 주목
    • RWE에서의 웨어러블 디바이스 및 인공지능 보급

제5장 규제 분석

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 기타 국가(RoW)

제6장 가격 결정 모델

  • 서론
  • 환자 기록별 과금(수량 기준 가격 결정)
  • 사용량별 과금(가치 기준 가격 결정)
  • 연간 구독 방식

제7장 세계의 RWE 솔루션 시장 : 컴포넌트별

  • 서론
  • 데이터 세트
    • 개별 데이터 세트
    • 통합 데이터 세트
  • 서비스

제8장 세계의 RWE 솔루션 시장 : 용도별

  • 서론
  • Drug Development & Approvals
    • 종양
    • 순환기질환
    • 신경증
    • 면역질환
    • 기타 치료 영역
  • 의료기기 개발/승인
  • 시장 접근, 의료비 상환/보험 보상 범위 결정
  • 임상 의사결정
  • 기타 용도

제9장 세계의 RWE 솔루션 시장 : 최종사용자별

  • 서론
  • 제약/바이오테크놀러지/의료기기 기업
  • 지불자
  • 의료 제공자
  • 기타 최종사용자

제10장 세계의 RWE 솔루션 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 기타 유럽 국가
  • 아시아태평양
    • 일본
    • 중국
    • 기타 아시아태평양 국가
  • 라틴아메리카
  • 중동 및 아프리카

제8장 경쟁 구도

  • 서론
  • 주요 성장 전략
  • 기업간 비교 분석
    • 분석 방법
  • 시장 점유율 분석(2019년)

제12장 기업 개요

  • IQVIA Holdings Inc.(미국)
  • ICON plc(아일랜드)
  • Parexel International Corporation(미국)
  • PPD Inc.(미국)
  • International Business Machines Corporation(미국)
  • UnitedHealth Group Incorporated(미국)
  • Oracle Corporation(미국)
  • SAS Institute Inc.(미국)
  • Anthem Inc.(미국)
  • Clinigen Group plc(영국)
  • Cognizant Technology Solutions(CTS) Corporation
  • PerkinElmer, Inc.(미국)

제13장 부록

LSH 20.12.14

List of Tables

  • Table 1 Global Real-World Evidence Solutions Market Drivers: Impact Analysis (2020-2027)
  • Table 2 Global Real-World Evidence Solutions Market Restraints: Impact Analysis (2020-2027)
  • Table 3 Global Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 4 Global Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 5 Global Real-World Evidence Solutions Datasets Market Size, by Country/Region 2018-2027 (USD Million)
  • Table 6 Global Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 7 Global Real-World Evidence Solutions Disparate Datasets Market Size, by Country/Region, 2018-2027 (USD Million)
  • Table 8 Global EMR/EHR/Clinical Datasets Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 9 Global Claims & Billing Data Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 10 Global Pharmacy Data Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 11 Global Product/Disease Registries Data Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 12 Global Other Disparate Datasets Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 13 Global Real-World Evidence Solutions Integrated Datasets Market Size, by Country/Region, 2018-2027 (USD Million)
  • Table 14 Global Services Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 15 Global Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 16 Global RWE Solutions Market Size for Drug Development & Approvals, by Therapeutic Area, 2018-2027 (USD Million)
  • Table 17 Global RWE Solutions Market Size for Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 18 Global RWE Solutions Market Size for Oncological Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 19 Global RWE Solutions Market Size for Cardiovascular Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 20 Global RWE Solutions Market Size for Neurology Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 21 Global RWE Solutions Market Size for Immunology Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 22 Global RWE Solutions Market Size for Other Therapeutic Areas Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 23 Global RWE Solutions Market Size for Market Access & Reimbursement/Coverage Decisions, by Country/Region, 2018-2027 (USD Million)
  • Table 24 Global RWE Solutions Market Size for Clinical Decision Making, by Country/Region, 2018-2027 (USD Million)
  • Table 25 Global RWE Solutions Market Size for Medical Device Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 26 Global RWE Solutions Market Size for Other Applications, by Country/Region, 2018-2027 (USD Million)
  • Table 27 Global Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 28 Global Real-World Evidence Solutions Market Size, for Pharmaceutical, Biotechnology, and Medical Device Companies, by Country/Region, 2018-2027 (USD Million)
  • Table 29 Global Real-World Evidence Solutions Market Size, for Healthcare Payers, by Country/Region, 2018-2027 (USD Million)
  • Table 30 Global Real-World Evidence Solutions Market Size, for Healthcare Providers, by Country/Region, 2018-2027 (USD Million)
  • Table 31 Global Real-World Evidence Solutions Market Size, for Other End Users, by Country/Region, 2018-2027 (USD Million)
  • Table 32 Global Real-World Evidence Solutions Market Size, by Country/Region, 2018-2027 (USD Million)
  • Table 33 North America: Real-World Evidence Solutions Market Size, by Country, 2018-2027 (USD Million)
  • Table 34 North America: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 35 North America: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 36 North America: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 37 North America: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 38 North America: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 39 U.S.: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 40 U.S.: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 41 U.S.: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 42 U.S.: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 43 U.S.: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 44 Canada: Real -World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 45 Canada: Real -World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 46 Canada: Real -World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 47 Canada: Real -World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 48 Canada: Real -World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 49 European: Real-World Evidence Solutions Market Size, by Country, 2018-2027 (USD Million)
  • Table 50 European: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 51 European: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 52 European: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 53 European: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 54 European: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 55 Germany: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 56 Germany: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 57 Germany: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 58 Germany: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 59 Germany: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 60 U.K.: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 61 U.K.: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 62 U.K.: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 63 U.K.: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 64 U.K.: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 65 France: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 66 France: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 67 France: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 68 France: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 69 France: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 70 Italy: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 71 Italy: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 72 Italy: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 73 Italy: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 74 Italy: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 75 Spain: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 76 Spain: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 77 Spain: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 78 Spain: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 79 Spain: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 80 RoE: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 81 RoE: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 82 RoE: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 83 RoE: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 84 RoE: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 85 Asia-Pacific: Real-World Evidence Solutions Market Size, by Country, 2018-2027 (USD Million)
  • Table 86 Asia-Pacific: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 87 Asia-Pacific: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 88 Asia-Pacific: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 89 Asia-Pacific: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 90 Asia-Pacific: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 91 Japan: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 92 Japan: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 93 Japan: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 94 Japan: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 95 Japan: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 96 China: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 97 China: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 98 China: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 99 China: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 100 China: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 101 RoAPAC: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 102 RoAPAC: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 103 RoAPAC: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 104 RoAPAC: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 105 RoAPAC: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 106 Latin America: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 107 Latin America: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 108 Latin America: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 109 Latin America: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 110 Latin America: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 111 Middle East & Africa: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 112 Middle East & Africa: Real-World Evidence Solutions Datasets Market Size, by Type, 2018- 2027 (USD Million)
  • Table 113 Middle East & Africa: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 114 Middle East & Africa: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 115 Middle East & Africa: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 116 Recent Developments, by Company, 2017-2020

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Real-World Evidence Solutions Market Size, by Component, 2020 Vs. 2027 (USD Million)
  • Figure 8 Global Real-World Evidence Solutions Market Size, by Application, 2020 Vs. 2027 (USD Million)
  • Figure 9 Regional Snapshot: Real-World Evidence Solutions Market
  • Figure 10 Global Real-World Evidence Solutions Market Size, by Component, 2020-2027 (USD Million)
  • Figure 11 Global Real-World Evidence Solutions Market Size, by Application, 2020-2027 (USD Million)
  • Figure 12 Global Real-World Evidence Solutions Market Size, by End User, 2020-2027 (USD Million)
  • Figure 13 Global Real-World Evidence Solutions Market Size, by Country/Region, 2020-2027 (USD Million)
  • Figure 14 North America: Real-World Evidence Solutions Market Snapshot
  • Figure 15 Europe: Real-World Evidence Solutions Market Snapshot
  • Figure 16 Asia-Pacific: Real-World Evidence Solutions Market Snapshot
  • Figure 17 Key Growth Strategies Adopted by Leading Players, 2017-2020
  • Figure 18 Real-World Evidence Solutions Market: Competitive Benchmarking

Real-World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development & Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027

The real-world evidence solutions market is expected to grow at a CAGR of 16.5% from 2020 to 2027 to reach USD 3.13 billion by 2027.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The growth in the real-world evidence solutions market is mainly attributed to the rising geriatric population and burden of chronic diseases, the shift towards value-based care, growing focus on personalized healthcare, delays in drug development and the subsequent increase in development costs, and expanding use of RWE for regulatory decision making. Moreover, growth opportunities in emerging markets; rising focus on end-to-end RWE services; and emerging roles of wearable devices, social media, and AI in RWE provide growth opportunities for players operating in the real-world evidence solutions market.

Based on component, in 2020, the datasets segment is expected to account for the largest share due to the increasing need for additional insights on epidemiology; compliance, adherence, and costs in a realistic environment; rise in demand for information by the payers, regulatory bodies, and providers with regards to drug safety; growing amount of medical data generated in hospitals and healthcare facilities; and increasing dependence on outcome-based studies on real-world data.

Based on application, the drug development and approvals segment is estimated to account for the largest share of the market in 2020. An increase in the demand of RWD and RWE to accelerate drug discovery & development, increasing investment by biopharmaceutical companies in R&D, and growing inclination of regulatory bodies towards RWE are expected to propel the growth of this segment.

In terms of end-users of real-world evidence solutions, pharmaceutical, biotech & medical device companies tend to use them extensively. The increasing importance of RWE studies in drug development and approvals, growing focus to avoid costly drug recalls, and the increasing need to assess drug performance in real-world settings are the factors driving this end-user segment.

An in-depth analysis of the real-world evidence solutions market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is estimated to account for the largest share of the real-world evidence solutions market in 2020, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa.

The key players operating in the real-world evidence solutions market are Anthem, Inc. (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation (U.S.), ICON plc (Ireland), IQVIA (U.S.), Optum (A Subsidiary of United Health Group, Inc.) (U.S.), Oracle Corporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), PPD Inc., (U.S.), SAS Institute Inc. (U.S.), and Syneos Health, Inc. (U.S.), among others.

Scope of the Report:

Real-world Evidence Solutions Market, by Component

  • Datasets
  • Disparate Datasets
  • EMR/EHR/Clinical data
  • Claims & Billing Data
  • Pharmacy Data
  • Product/Disease Registries Data
  • Other Disparate Datasets
  • Integrated Datasets
  • Services

Other disparate datasets comprise data gathered from other sources that can inform health statuses, such as mobile devices, wearable devices, and social media.

Real-world Evidence Solutions Market, by Application

  • Drug Development & Approvals
  • Oncology
  • Cardiovascular Disease
  • Neurology
  • Immunology
  • Others Therapeutic Areas

Other therapeutic areas comprise infectious diseases, musculoskeletal disorders, dermatological diseases, and respiratory diseases.

  • Medical Device Development & Approvals
  • Market Access & Reimbursement/Coverage Decisions
  • Clinical Decision-Making
  • Other Applications

Other applications comprise regulatory decision-making, post-approval monitoring, and post-market device surveillance.

Real-world Evidence Solutions Market, by End User

  • Pharmaceutical, Biotechnology & Medical Device Companies
  • Healthcare Payers
  • Healthcare Providers
  • Other End Users

Other end-users comprise academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies.

Real-world Evidence Solutions Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Growing Burden of Chronic Diseases in Geriatric Population
    • 4.2.2. Delays in Drug Development and the Subsequent Increase in Development Costs
    • 4.2.3. Rising Focus Towards Personalized Healthcare
    • 4.2.4. Shift Towards Value-Based Care
    • 4.2.5. Impact Assessment of COVID-19
    • 4.2.6. Rapidly Growing Big Data in Healthcare
  • 4.3. Restraints
    • 4.3.1. Reluctance to Rely on Real-World Studies
  • 4.4. Challenges
    • 4.4.1. Lack of Standardized Methodologies to Develop RWE
  • 4.5. Opportunities
    • 4.5.1. Emerging Economies
    • 4.5.2. Rising Focus on End-to-End RWE Services
    • 4.5.3. Rising Adoption of Wearable Devices and Artificial Intelligence in RWE

5. Regulatory Analysis

  • 5.1. Introduction
  • 5.2. North America
  • 5.3. Europe
  • 5.4. Asia-Pacific
  • 5.5. Rest of the World

6. Pricing Models

  • 6.1. Introduction
  • 6.2. Pay Per Patient Record (Volume-Based Pricing)
  • 6.3. Pay Per Usage (Value-Based Pricing)
  • 6.4. Annual Subscription

7. Global Real-World Evidence Solutions Market, by Component

  • 7.1. Introduction
  • 7.2. Datasets
    • 7.2.1. Disparate Datasets
      • 7.2.1.1. EMR/EHR/Clinical Data
      • 7.2.1.2. Claims & Billing Data
      • 7.2.1.3. Pharmacy Data
      • 7.2.1.4. Product/Disease Registries Data
      • 7.2.1.5. Others
    • 7.2.2. Integrated Datasets
  • 7.3 Services

8. Global Real-World Evidence Solutions Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Development & Approvals
    • 8.2.1 Oncology
    • 8.2.2 Cardiovascular Disease
    • 8.2.3 Neurology
    • 8.2.4 Immunology
    • 8.2.5 Others Therapeutic Areas
  • 8.3. Medical Device Development & Approvals
  • 8.4. Market Access & Reimbursement/Coverage Decisions
  • 8.5. Clinical Decision-Making
  • 8.6. Other Applications

9. Global Real-World Evidence Solutions Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmaceutical, Biotechnology & Medical Device Companies
  • 9.3. Healthcare Payers
  • 9.4. Healthcare Providers
  • 9.5. Other End Users

10. Global Real-World Evidence Solutions Market, by Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. Rest of Asia-Pacific
  • 10.5. Latin America
  • 10.6. Middle East & Africa

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
    • 11.3.1. Competitive Benchmarking, by Methodology
  • 11.4. Market Share Analysis (2019)

12. Company Profiles

  • 12.1. IQVIA Holdings Inc. (U.S.)
  • 12.2. ICON plc (Ireland)
  • 12.3. Parexel International Corporation (U.S.)
  • 12.4. PPD Inc. (U.S.)
  • 12.5. International Business Machines Corporation (U.S.)
  • 12.6. UnitedHealth Group Incorporated (U.S.)
  • 12.7. Oracle Corporation (U.S.)
  • 12.8. SAS Institute Inc. (U.S.)
  • 12.9. Anthem Inc. (U.S.)
  • 12.10 Clinigen Group plc (U.K.)
  • 12.11 Cognizant Technology Solutions (CTS) Corporation
  • 12.12. PerkinElmer, Inc. (U.S.)

13. Appendix

  • 13.1. Questionnaire
  • 13.2. Available Customization
Back to Top
전화 문의
F A Q